A Systematic Patent Review (2008-2023) for Treatment in Pregnancy


Cite item

Full Text

Abstract

Introduction:During pregnancy, the woman’s body undergoes anatomical and physiological changes, making this period susceptible to maternal-fetal diseases and complications. The consequences of not treating pregnant women include premature birth, low birth weight fetuses, and postnatal behavior disorders. Developing new therapies can accelerate the discovery of safe and effective drugs, contributing to designing novel natural and synthetic products to treat complications the pregnancy.

Objective:This study aimed to carry out a patent review to identify and explore trends in innovation and therapeutic strategies for treating pregnant women.

Methods:The Espacenet and WIPO databases were used, with the inclusion criteria being the keywords "pregnancy and drug" and code A61k, from 2008 to 2023, and as exclusion were the access to the patent and focus on human pregnant women.

Results:After the final screening, 32 patents were selected, with strategies for the treatment of diseases in pregnant women. Of these, 20 patents are on preclinical studies on animals and 12 on pregnant women. It was observed that universities lead the ranking of applications (17/32), and China has the highest number of patents (18/32). Most findings contain herbal medicines and/or the association of natural extracts with synthetic drugs.

Conclusion:From this perspective, new drug administration systems were also developed, which can be a promising source for obtaining new medicines for the treatment of pregnant women; however, research is still limited and shows a gap in stimulating the rapid development of safe drugs that improve the health of pregnant women.

About the authors

Kélle Pereira

Graduate Program in Pharmaceutical Sciences, Federal University of Santa Maria, UFSM

Email: info@benthamscience.net

Camila Pacheco

Graduate Program in Pharmaceutical Sciences,, Federal University of Santa Maria, UFSM

Email: info@benthamscience.net

Izabel Alves

Department of Medicines, Faculty of Pharmacy, Federal University of Bahia, UFBA

Email: info@benthamscience.net

Sandra Haas

Graduate Program in Pharmaceutical Sciences,, Federal University of Santa Maria, UFSM

Author for correspondence.
Email: info@benthamscience.net

References

  1. Kazma, J.M.; van den Anker, J.; Allegaert, K.; Dallmann, A.; Ahmadzia, H.K. Anatomical and physiological alterations of pregnancy. J. Pharmacokinet. Pharmacodyn., 2020, 47(4), 271-285. doi: 10.1007/s10928-020-09677-1 PMID: 32026239
  2. Cabrera, R.M.; Linda Lin, Y.; Law, E.; Kim, J.; Wlodarczyk, B.J. The teratogenic effects of sertraline in mice. Birth Defects Res., 2020, 112(13), 1014-1024. doi: 10.1002/bdr2.1660 PMID: 32077266
  3. Dabb, C.; Dryer, R.; Brunton, R.J.; Yap, K.; Roach, V.J. Paternal pregnancy-related anxiety: Systematic review of men’s concerns and experiences during their partners’ pregnancies. J. Affect. Disord., 2023, 323, 640-658. doi: 10.1016/j.jad.2022.11.092 PMID: 36481231
  4. Racicot, K.; Kwon, J.Y.; Aldo, P.; Silasi, M.; Mor, G. Understanding the complexity of the immune system during pregnancy. Am. J. Reprod. Immunol., 2014, 72(2), 107-116. doi: 10.1111/aji.12289 PMID: 24995526
  5. Shook, L.L.; Kislal, S.; Edlow, A.G. Fetal brain and placental programming in maternal obesity: A review of human and animal model studies. Prenat. Diagn., 2020, 40(9), 1126-1137. doi: 10.1002/pd.5724 PMID: 32362000
  6. Alegre-Del Rey, E.J.; Fénix-Caballero, S.; Díaz-Navarro, J. Risk of medications in pregnancy: A problem of knowledge transfer with ethical repercussions. Cuad. Bioet., 2019, 30(99), 199-207. PMID: 31206299
  7. Sun, C.; Groom, K.M.; Oyston, C.; Chamley, L.W.; Clark, A.R.; James, J.L. The placenta in fetal growth restriction: What is going wrong? Placenta, 2020, 96, 10-18. doi: 10.1016/j.placenta.2020.05.003 PMID: 32421528
  8. Marx, U.; Akabane, T.; Andersson, T.B.; Baker, E.; Beilmann, M.; Beken, S.; Brendler-Schwaab, S.; Cirit, M.; David, R.; Dehne, E.M.; Durieux, I.; Ewart, L.; Fitzpatrick, S.C.; Frey, O.; Fuchs, F.; Griffith, L.G.; Hamilton, G.A.; Hartung, T.; Hoeng, J.; Hogberg, H.; Hughes, D.J.; Ingber, D.E.; Iskandar, A.; Kanamori, T.; Kojima, H.; Kuehnl, J.; Leist, M.; Li, B.; Loskill, P.; Mendrick, D.L.; Neumann, T.; Pallocca, G.; Rusyn, I.; Smirnova, L.; Steger-Hartmann, T.; Tagle, D.A.; Tonevitsky, A.; Tsyb, S.; Trapecar, M.; Van de Water, B.; Van den Eijnden-van Raaij, J.; Vulto, P.; Watanabe, K.; Wolf, A.; Zhou, X.; Roth, A. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. Altern. Anim. Exp., 2020, 37(3), 365-394. PMID: 32113184
  9. Mitchell, A.A. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol, 2011, 51.
  10. David, A.L.; Ahmadzia, H.; Ashcroft, R.; Bucci-Rechtweg, C.; Spencer, R.N.; Thornton, S. Improving development of drug treatments for pregnant women and the fetus. Ther. Innov. Regul. Sci., 2022, 56(6), 976-990. doi: 10.1007/s43441-022-00433-w PMID: 35881237
  11. Waggoner, M.R.; Lyerly, A.D. Clinical trials in pregnancy and the "shadows of thalidomide": Revisiting the legacy of Frances Kelsey. Contemp. Clin. Trials, 2022, 119, 106806. doi: 10.1016/j.cct.2022.106806 PMID: 35654303
  12. Figueroa-Espada, C.G.; Hofbauer, S.; Mitchell, M.J.; Riley, R.S. Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy. Adv. Drug Deliv. Rev., 2020, 160, 244-261. doi: 10.1016/j.addr.2020.09.006 PMID: 32956719
  13. Giacomeli, R.; Guerra Teixeira, F.E.; Carvalho, F.B.; Pacheco, C.O.; Martins Parisotto, A.J.; Funguetto Ribeiro, A.C.; Gomes de Gomes, M.; Haas, S.E. Curcumin-loaded poly(ϵ-caprolactone) lipid-core nanocapsules: Evaluation of fetal and maternal toxicity. Food Chem. Toxicol., 2020, 144, 111625. doi: 10.1016/j.fct.2020.111625 PMID: 32738367
  14. Sueth-Santiago, V. Curcumin, the golden powder of turmeric: insights into chemistry and biological activities. Quim. Nova, 2015, 38, 538-552.
  15. Mendes, M.L.S.; Melo, D.R.A. Technology assessment: A methodological proposal. Contemp. Adm. Mag., 2017, 21(4), 569-584. doi: 10.1590/1982-7849rac2017170047
  16. Ponta, L.; Puliga, G.; Manzini, R. A measure of innovation performance: The Innovation Patent Index. Manage. Decis., 2021, 59(13), 73-98. doi: 10.1108/MD-05-2020-0545
  17. Ribeiro, B.; Shapira, P. Private and public values of innovation: A patent analysis of synthetic biology. Res. Policy, 2020, 49(1), 103875. doi: 10.1016/j.respol.2019.103875 PMID: 32015589
  18. Han, Y.J. Measuring industrial knowledge stocks with patents and papers. J. Informetrics, 2007, 1(4), 269-276. doi: 10.1016/j.joi.2007.06.001
  19. Cockburn, I.; Long, G. The importance of patents to innovation: Updated cross-industry comparisons with biopharmaceuticals. Expert Opin. Ther. Pat., 2015, 25(7), 739-742. doi: 10.1517/13543776.2015.1040762 PMID: 25927945
  20. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; Chou, R.; Glanville, J.; Grimshaw, J.M.; Hróbjartsson, A.; Lalu, M.M.; Li, T.; Loder, E.W.; Mayo-Wilson, E.; McDonald, S.; McGuinness, L.A.; Stewart, L.A.; Thomas, J.; Tricco, A.C.; Welch, V.A.; Whiting, P.; Moher, D. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 2021, 372, n71. doi: 10.1136/bmj.n71 PMID: 33782057
  21. Geum, Y.; Kim, M. How to identify promising chances for technological innovation: Keygraph-based patent analysis. Adv. Eng. Inform., 2020, 46, 101155. doi: 10.1016/j.aei.2020.101155
  22. Dantas, S.L.C.; Oliveira, G.Y.M.; Costa, K.F.L.; Barros, A.A.; Chaves, E.M.C.; Carvalho, R.E.F.L. Experimental studies in the gestational period: overview of scientific production. Rev. Esc. Enferm. USP, 2018, 52(0), 52. doi: 10.1590/s1980-220x2017024403325
  23. Bannerman, S. The world intellectual property organization and the sustainable development agenda. Futures, 2020, 122, 102586. doi: 10.1016/j.futures.2020.102586
  24. Palazzani, L. Clinical trials in the time of a pandemic: Implications for informed consent. BioLaw J., 2021, (2S), 35-50.
  25. Joshi, M.D. Drug delivery during pregnancy: How can nanomedicine be used?; Future Science, 2017.
  26. Ambros-Rudolph, C.M. Disorders of pregnancy. In: Braun-Falco´s Dermatology; Springer, 2022; pp. 1501-1512. doi: 10.1007/978-3-662-63709-8_81
  27. Cairns, A.E.; Tucker, K.L.; Leeson, P.; Mackillop, L.; McManus, R.J. Survey of healthcare professionals regarding adjustment of antihypertensive medication(s) in the postnatal period in women with hypertensive disorders of pregnancy. Pregnancy Hypertens., 2016, 6(4), 256-258. doi: 10.1016/j.preghy.2016.08.240 PMID: 27939462
  28. Malha, L.; Podymow, T.; August, P. Hypertension in pregnancy. In: Hypertension; Elsevier, 2024; pp. 501-517. doi: 10.1016/B978-0-323-88369-6.00044-X
  29. Zhang, B.; Liang, R.; Zheng, M.; Cai, L.; Fan, X. Surface- functionalized nanoparticles as efficient tools in targeted therapy of pregnancy complications. Int. J. Mol. Sci., 2019, 20(15), 3642. doi: 10.3390/ijms20153642 PMID: 31349643
  30. Kamilevna, P.M.M. Method for preeclampsia prevention; World Intellectual Property Organization.: Russian, 2019.
  31. Kuciene, R.; Dulskiene, V. Associations of maternal gestational hypertension with high blood pressure and overweight/obesity in their adolescent offspring: A retrospective cohort study. Sci. Rep., 2022, 12(1), 3800. doi: 10.1038/s41598-022-07903-z PMID: 35260718
  32. Phipps, E.A.; Thadhani, R.; Benzing, T.; Karumanchi, S.A. Pre-eclampsia: Pathogenesis, novel diagnostics and therapies. Nat. Rev. Nephrol., 2019, 15(5), 275-289. doi: 10.1038/s41581-019-0119-6 PMID: 30792480
  33. Yanjuan, B.I. Obstetrical and gynecological drug for treating complications of pregnancy and preparation method thereof. In: Espacenet; Ltd, B.Y.T.C., Ed.; China, 2018.
  34. Zhou, L. Astragalus membranaceus and Salvia miltiorrhiza ameliorate hypertensive renal damage through lncRNA-mRNA coexpression network. BioMed Res Int, 2022, 2022, 3002353. doi: 10.1155/2022/3002353
  35. Fangjun, X.I.A. Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof. C.N. Patent 104258292A, 2015.
  36. Du, T.T.H.U.T.D.U.X. Use of zanamivir in preparation of drug for treating or preventing preeclampsia. W.O. Patent 2022111543, 2022.
  37. Lu, Y.; Chen, R.; Cai, J.; Huang, Z.; Yuan, H. The management of hypertension in women planning for pregnancy. Br. Med. Bull., 2018, 128(1), 75-84. doi: 10.1093/bmb/ldy035 PMID: 30371746
  38. Honigberg, M.C.; Zekavat, S.M.; Aragam, K.; Klarin, D.; Bhatt, D.L.; Scott, N.S.; Peloso, G.M.; Natarajan, P. Long-term cardiovascular risk in women with hypertension during pregnancy. J. Am. Coll. Cardiol., 2019, 74(22), 2743-2754. doi: 10.1016/j.jacc.2019.09.052 PMID: 31727424
  39. Hyo-eun, B.Y. Composition comprising htr3a agonist for preventing arrhythmia or cardiac death. K.R. Patent 101694780, 2017.
  40. Li, C.; Jia, W.; Yang, J.; Cheng, C.; Olaleye, O.E. Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines. Acta Pharmacol. Sin., 2022, 43(12), 3080-3095. doi: 10.1038/s41401-022-00983-7 PMID: 36114271
  41. Xiaoyun, J. CN106668023 Drug composition for treating pregnancy-induced hypertension. C.N. Patent 106668023, 2017.
  42. Lind, J.M.; Hennessy, A.; Chiu, C.L. Association between a woman’s age at first birth and high blood pressure. Medicine, 2015, 94(16), e697. doi: 10.1097/MD.0000000000000697 PMID: 25906097
  43. Xiaowei, H.Y.; Guo, C.N. Obstetrics and gynecology drug for treating complication of pregnancy and preparation method thereof. C.N. Patent 109893586 , 2017.
  44. Wang, H.; Rolls, E.T.; Du, X.; Du, J.; Yang, D.; Li, J.; Li, F.; Cheng, W.; Feng, J. Severe nausea and vomiting in pregnancy: psychiatric and cognitive problems and brain structure in children. BMC Med., 2020, 18(1), 228. doi: 10.1186/s12916-020-01701-y PMID: 32867775
  45. Bustos, M.; Venkataramanan, R.; Caritis, S. Nausea and vomiting of pregnancy - What’s new? Auton. Neurosci., 2017, 202, 62-72. doi: 10.1016/j.autneu.2016.05.002 PMID: 27209471
  46. Res, F.B.S. Drug composition for treating vomiting during pregnancy. C.N. Patent 103432126A, 2013.
  47. Abramowitz, A.; Miller, E.S.; Wisner, K.L. Treatment options for hyperemesis gravidarum. Arch. Women Ment. Health, 2017, 20(3), 363-372. doi: 10.1007/s00737-016-0707-4 PMID: 28070660
  48. Mandaogade, P.M.; Ma, D.; Talwar, N. Disintegrant-free delayed release doxylamine and pyridoxine formulation and process of manufacturing. C.N. Patent 2858478A1, 2014.
  49. Zhenhua, H. Pharmaceutical composition for gestation reaction and method of preparing the same. C.N. Patent 101138621, 2008.
  50. Allais, G.; Chiarle, G.; Sinigaglia, S.; Mana, O.; Benedetto, C. Migraine during pregnancy and in the puerperium. Neurol. Sci., 2019, 40(S1)(Suppl. 1), 81-91. doi: 10.1007/s10072-019-03792-9 PMID: 30880362
  51. Burch, R.C.; Buse, D.C.; Lipton, R.B. Migraine. Neurol. Clin., 2019, 37(4), 631-649. doi: 10.1016/j.ncl.2019.06.001 PMID: 31563224
  52. Jin Gp, J.X.Z.H.Z.E.H. Medicine for treating migraine during pregnancy. C.N. Patent 111481625, 2020.
  53. Islam, A.; Fawad, A.; Shah, A.A.; Jadoon, H.; Sarwar, I.; Abbasi, A.U. Analysis of two years cases of ectopic pregnancy. J. Ayub Med. Coll. Abbottabad, 2017, 29(1), 65-67. PMID: 28712177
  54. Xinglan, L. Medicine taken orally for the treatment of old ectopic pregnancy and method of preparation thereof. C.N. Patent 104800434, 2015.
  55. Vladimirovich, Z.R.S. Method for preventing chronic hypoxia and foetal development retardation. R.U. Patent 0002699559, 2019.
  56. Zavadenko, N.N.; Suvorinova, N.Iu.; Rumiantseva, M.V.; Ovchinnikova, A.A. The use of instenon in children with minimal brain dysfunction. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, 2002, 102(5), 29-35. PMID: 12087730
  57. Sorouri, K.; Loren, A.W.; Amant, F.; Partridge, A.H. Patient-centered care in the management of cancer during pregnancy. Am. Soc. Clin. Oncol. Educ. Book, 2023, 43(43), e100037. doi: 10.1200/EDBK_100037 PMID: 37220323
  58. Piccinni, G.; Clark, C.; Cagnazzo, E. Acute abdomen of non-obstetric origin in pregnancy. In: Practical Guide to Simulation in Delivery Room Emergencies; Springer, 2023; pp. 97-112. doi: 10.1007/978-3-031-10067-3_5
  59. Zachariah, S.K.; Fenn, M.; Jacob, K.; Arthungal, S.A.; Zachariah, S.A. Management of acute abdomen in pregnancy: Current perspectives. Int. J. Womens Health, 2019, 11, 119-134. doi: 10.2147/IJWH.S151501 PMID: 30804686
  60. Lei, S.D. Drug for treating abdominal pain during pregnancy. C.N. Patent 103386001, 2013.
  61. Hualun, D. Chinese herbal medicine for curing hypogastric pain in pregnancy for women. C.N. Patent 101904965, 2010.
  62. Barbitoff, Y.A.; Tsarev, A.A.; Vashukova, E.S.; Maksiutenko, E.M.; Kovalenko, L.V.; Belotserkovtseva, L.D.; Glotov, A.S. A data-driven review of the genetic factors of pregnancy complications. Int. J. Mol. Sci., 2020, 21(9), 3384. doi: 10.3390/ijms21093384 PMID: 32403311
  63. Zhibin, L.H. Novel application of Chinese herbal compound pharmaceutical composition. C.N. Patent 104352711, 2015.
  64. Hao, C. Nutrient preparation for promoting pregnancy and preventing miscarriage. C.N. Patent 109288067, 2019.
  65. Sharifi-Rad, M.; Anil Kumar, N.V.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Tsouh Fokou, P.V.; Azzini, E.; Peluso, I.; Prakash Mishra, A.; Nigam, M.; El Rayess, Y.; Beyrouthy, M.E.; Polito, L.; Iriti, M.; Martins, N.; Martorell, M.; Docea, A.O.; Setzer, W.N.; Calina, D.; Cho, W.C.; Sharifi-Rad, J. Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front. Physiol., 2020, 11, 694. doi: 10.3389/fphys.2020.00694 PMID: 32714204
  66. Kamilevna, P.M.M.; Olina Anna, A.; Sadykova, G. Method of treatment of threatened preterm labor. World Intellectual Property Organization. R.U. Patent 0002578476, 2016.
  67. Chechko, N.; Losse, E.; Nehls, S. Pregnancy denial: Toward a new understanding of the underlying mechanisms. Curr. Psychiatry Rep., 2023, 25(10), 493-500. doi: 10.1007/s11920-023-01448-2 PMID: 37597131
  68. Wicklow, B.; Retnakaran, R. Gestational diabetes mellitus and its implications across the life span. Diabetes Metab. J., 2023, 47(3), 333-344. doi: 10.4093/dmj.2022.0348 PMID: 36750271
  69. Choudhury, A.A.; Devi Rajeswari, V. Gestational diabetes mellitus - A metabolic and reproductive disorder. Biomed. Pharmacother., 2021, 143, 112183. doi: 10.1016/j.biopha.2021.112183 PMID: 34560536
  70. Kim, S.Y.; England, L.; Wilson, H.G.; Bish, C.; Satten, G.A.; Dietz, P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am. J. Public Health, 2010, 100(6), 1047-1052. doi: 10.2105/AJPH.2009.172890 PMID: 20395581
  71. Wikens, C.L.W.K.L. Use of lactic acid bacteria for treating or preventing gestational diabetes mellitus. R.U. Patent 0002769312, 2022.
  72. Mhata, N.T.; Ntlantsana, V.; Tomita, A.M.; Mwambene, K.; Saloojee, S. Prevalence of depression, anxiety and burnout in medical students at the University of Namibia. S. Afr. J. Psychiatry, 2023, 29(1), 2044. doi: 10.4102/sajpsychiatry.v29i0.2044 PMID: 37292521
  73. Yuan, L.; Li, Y.; Yan, H.; Xiao, C.; Liu, D.; Liu, X.; Guan, Y.; Yu, B. Effects of work-family conflict and anxiety in the relationship between work-related stress and job burnout in Chinese female nurses: A chained mediation modeling analysis. J. Affect. Disord., 2023, 324, 309-316. doi: 10.1016/j.jad.2022.12.112 PMID: 36586602
  74. Keshavarz, M.; Amzajerdi, A.; Montazeri, A.; Bekhradi, R. Effect of mint aroma on nausea, vomiting and anxiety in pregnant women. J. Family Med. Prim. Care, 2019, 8(8), 2597-2601. doi: 10.4103/jfmpc.jfmpc_480_19 PMID: 31548939
  75. Fang, W. Medicinal vinegar preventing and treating anxiety in pregnancy caused by yin deficiency; WIPO: China, 2018.
  76. Siddiqui, S.A.; Ali Redha, A.; Snoeck, E.R.; Singh, S.; Simal-Gandara, J.; Ibrahim, S.A.; Jafari, S.M. Anti-depressant properties of crocin molecules in saffron. Molecules, 2022, 27(7), 2076. doi: 10.3390/molecules27072076 PMID: 35408474
  77. Bianzhu, C. Vinegar preparation preventing and treating dizziness in pregnancy caused by qi and blood deficiency. C.N. Patent 108635462, 2018.
  78. Wang, XiaoMeng Impact of Qi-invigorating traditional Chinese medicines on intestinal flora: A basis for rational choice of prebiotics. Chin J Nat Med., 2017, 15(4), 241-254.
  79. Bravo, J.A.; Forsythe, P.; Chew, M.V.; Escaravage, E.; Savignac, H.M.; Dinan, T.G.; Bienenstock, J.; Cryan, J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA, 2011, 108(38), 16050-16055. doi: 10.1073/pnas.1102999108 PMID: 21876150
  80. Slickerman, R. Use of lactic acid bacteria for treatment or prevention of at least one condition of postnatal depression and postnatal anxiety R.U. Patent 0002763172, 2021.
  81. Liang, H.; Yan, J. Infection and Sepsis, in Explosive Blast Injuries: Principles and Practices; Springer, 2023, pp. 227-252. doi: 10.1007/978-981-19-2856-7_15
  82. Anatol’evich, M.V.I. Drug preparation for toxicosis relief in early pregnancy exhibiting immune corrective, diuretic action. R.U. Patent 02381032, 2010.
  83. FÁTima, De. Molecules that stimulate the immune system for treatment of drug addiction, methods of synthesis, antidrug vaccine and uses. W.O. Patent 2019021140, 2019.
  84. Dahan, O. Birthing as an experience of awe: Birthing consciousness and its long-term positive effects. J. Theor. Philos. Psychol., 2023, 43(1), 16-30. doi: 10.1037/teo0000214
  85. Gau, M.L.; Chang, C.Y.; Tian, S.H.; Lin, K.C. Effects of birth ball exercise on pain and self-efficacy during childbirth: A randomised controlled trial in Taiwan. Midwifery, 2011, 27(6), e293-e300. doi: 10.1016/j.midw.2011.02.004 PMID: 21459499
  86. Haipeng, S.J.; Zhang, J.; Guo, C.N. Traditional chinese medicine composition for promoting head delivery of mares at late pregnancy. C.N. Patent 103800594, 2014.
  87. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod., 2016, 79(3), 629-661. doi: 10.1021/acs.jnatprod.5b01055 PMID: 26852623
  88. Xu, Y.X.Z.; Xi, S.; Qian, X. Evaluating traditional chinese medicine and herbal products for the treatment of gestational diabetes mellitus. J. Diabetes Res., 2019. doi: 10.1155/2019/9182595
  89. Illamola, S.M.; Amaeze, O.U.; Krepkova, L.V.; Birnbaum, A.K.; Karanam, A.; Job, K.M.; Bortnikova, V.V.; Sherwin, C.M.T.; Enioutina, E.Y. Use of herbal medicine by pregnant women: What physicians need to know. Front. Pharmacol., 2020, 10, 1483. doi: 10.3389/fphar.2019.01483 PMID: 31998122
  90. Brown, B.; Wright, C. Safety and efficacy of supplements in pregnancy. Nutr. Rev., 2020, 78(10), 813-826. doi: 10.1093/nutrit/nuz101 PMID: 31925443
  91. Shand, A.W.; Walls, M.; Chatterjee, R.; Nassar, N.; Khambalia, A.Z. Dietary vitamin, mineral and herbal supplement use: A cross-sectional survey of before and during pregnancy use in Sydney, Australia. Aust. N. Z. J. Obstet. Gynaecol., 2016, 56(2), 154-161. doi: 10.1111/ajo.12414 PMID: 26490392
  92. Zhao, X.; Jiang, Y.; Zhao, Y.; Xi, H.; Liu, C.; Qu, F.; Feng, X. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening. Eur. J. Clin. Microbiol. Infect. Dis., 2020, 39(7), 1209-1220. doi: 10.1007/s10096-020-03897-6 PMID: 32328850
  93. de Araújo, T.E.; Milián, I.C.B.; de Souza, G.; da Silva, R.J.; Rosini, A.M.; Guirelli, P.M.; Franco, P.S.; Barbosa, B.F.; Ferro, E.A.V.; da Costa, I.N. Experimental models of maternal–fetal interface and their potential use for nanotechnology applications. Cell Biol. Int., 2020, 44(1), 36-50. doi: 10.1002/cbin.11222 PMID: 31469205
  94. Joshi, G.; Patel, M.; Chaudhary, D.; Sawant, K. Preparation and surface modification of polymeric nanoparticles for drug delivery: State of the art. Recent Pat. Drug Deliv. Formul., 2021, 14(3), 201-213. doi: 10.2174/1872211314666200904105036 PMID: 32885767
  95. Jian, F.X. Placenta targeted delivery system and preparation method and application thereof. C.N. Patent 109568268, 2019.
  96. Xietong, J.Y. Preparation of placenta targeted nano-drug and application of placenta targeted nano-drug in treatment of pregnancy combined with autoimmune diseases. C.N. Patent 115054587, 2022.
  97. Cabral, H. Pharmaceutical composition for administration to pregnant women or women who may be pregnant. W.O. Patent 2020209379, 2020.
  98. Masafumi, M.E.; Tsujimoto, J.P. Drug for controlling labor pain and treating premature birth. J.P. Patent 2009269823, 2009.
  99. John, M.S. Medical drug delivery systems. U.S. Patent 20200222628, 2020.
  100. Peng, J. Device for applying medicine to vagina during pregnancy. C.N. Patent 215309581, 2021.
  101. Yu, W.H.; Wang, Q.; Kong, C.N. Gelatin sponge drug-loaded particle and preparation method thereof. C.N. Patent 110638762, 2020.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers